Amgen
Fighting the World's Toughest Diseases
Amgen harnesses the best of biology and technology to make people's lives easier, fuller, and longer.
"This is an extraordinary time for biotechnology. Science and technology are accelerating the cadence of innovation."Robert A. Bradway, Amgen CEO
A Biotech Leader
Amgen helped establish the biotechnology industry more than 40 years ago and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today.
Our investment in research and development over the past five years has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
We focus on four therapeutic areas, delivering innovative medicines to help people live longer, fuller, happier lives.
Oncology
Inflammation
General Medicine
Rare Disease
Science & Innovation
Amgen's powerful research and development group uses cutting-edge tools like AI, generative biology and human data to discover and develop new types of medicines to fight the world's toughest diseases.
Making Medicines Safely & Reliably
Many of Amgen's medicines are made through a highly complex process involving living cells. Our commitment is to deliver for "every patient, every time", and we have a long-running reputation for the reliability of our supply chain.
Operating Responsibly
Making a positive difference in the world is at the heart of what we do at Amgen — and it goes beyond making vital medicines.
We also help build a better world by focusing on environmental, social and governance (ESG) issues that matter most to our business and our stakeholders.